More on ANNX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+29.4% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Annexon (NQ:ANNX)
Delayed: 5.80 -0.09 (1.53%)
Prev. Close $5.89  
Open$5.75 
52 Wk High$ 
52 Wk Low$ 
Day High$6.16 
Day Low$5.68 
P/E N/A  
EPS$ 
Volume3,341,398 

Friends, Peers and Foes (?): GRAY LUMO (more...)

Jul 16, 2026 04:05 PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Jul 15, 2026 04:20 PM Form 144 Annexon, Inc. Filed by: WIGGANS THOMAS G
Jul 15, 2026 07:27 AM Annexon Biosciences (ANNX) PT Raised to $25 at Needham
Jul 14, 2026 04:05 PM Annexon to present Phase 2 GA trial data at ASRS 2026 meeting
Jul 14, 2026 04:05 PM Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
Jul 14, 2026 01:57 PM Form 144 Annexon, Inc. Filed by: WIGGANS THOMAS G
Jul 13, 2026 07:39 AM Annexon Biosciences (ANNX) Reiterate at Overweight by Cantor Fitzgerald on Vonaprument
Jul 8, 2026 09:30 PM Form SCHEDULE 13G/A Annexon, Inc. Filed by: Redmile Group, LLC
Jul 8, 2026 10:12 AM Form SCHEDULE 13G/A Annexon, Inc. Filed by: FMR LLC
Jun 16, 2026 04:05 PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with ANNX

View All Entities